Skip to main content
TipRanks
Go Ultimate75% OFF

Vivani Medical (VANI) Ratios

826 Followers

Vivani Medical Ratios

VANI's free cash flow for Q3 2026 was $-6.39M. For the 2026 fiscal year, VANI's free cash flow was increased by $0.00 and operating cash flow was $-6.39M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Mar 25Dec 23Mar 23Dec 21
Liquidity Ratios
Current Ratio2.713.414.036.971.18
Quick Ratio2.713.414.036.971.18
Cash Ratio2.463.073.616.611.04
Solvency Ratio-1.11-0.96-1.01-1.98-4.16
Operating Cash Flow Ratio-3.68-3.47-4.14-2.75-5.25
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ -5.76M$ -3.51M$ -1.97M$ 40.71M$ -519.00K
Leverage Ratios
Debt-to-Assets Ratio0.480.460.450.020.33
Debt-to-Equity Ratio1.201.101.000.020.74
Debt-to-Capital Ratio0.550.520.500.020.42
Long-Term Debt-to-Capital Ratio0.520.000.000.000.00
Financial Leverage Ratio2.502.362.211.152.21
Debt Service Coverage Ratio0.000.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.220.000.000.000.00
Interest Debt Per Share0.300.350.410.020.05
Net Debt to EBITDA-0.10-0.04-0.002.300.03
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT96.56%95.17%95.13%65.39%95.87%
Return on Assets (ROA)-67.55%-56.51%-56.01%-27.16%-234.24%
Return on Equity (ROE)-169.16%-133.37%-123.56%-31.35%-518.17%
Return on Capital Employed (ROCE)-84.04%-69.37%-67.29%-47.94%-395.69%
Return on Invested Capital (ROIC)-79.68%-66.83%-65.04%-46.93%-311.50%
Return on Tangible Assets-67.55%-56.51%-56.01%-27.16%-234.24%
Earnings Yield-34.67%-36.82%-49.45%-42.74%-7.21%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.410.000.660.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle-888.400.00-554.150.000.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding888.400.00554.150.000.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.39-0.38-0.47-0.49-0.30
Free Cash Flow Per Share-0.41-0.39-0.48-0.50-0.32
Dividend Paid and CapEx Coverage Ratio-20.73-37.38-26.72-55.58-19.15
Capital Expenditure Coverage Ratio-20.73-37.38-26.72-55.58-19.15
Operating Cash Flow Coverage Ratio-1.29-1.08-1.15-19.67-6.04
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-33.22%-33.46%-47.40%-58.86%-6.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-2.86-2.70-2.02-2.34-13.88
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio4.883.622.500.7371.91
Price-to-Free Cash Flow (P/FCF) Ratio-3.01-2.99-2.11-1.70-15.38
Price-to-Operating Cash Flow Ratio-3.16-3.07-2.19-1.73-16.19
Price-to-Earnings Growth (PEG) Ratio0.000.19-0.010.050.00
Enterprise Value Multiple-3.03-2.80-2.050.61-13.63
Enterprise Value79.36M64.74M51.91M-11.63M176.90M
EV to EBITDA-3.03-2.80-2.050.61-13.63
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-3.11-3.03-2.110.61-15.35
EV to Operating Cash Flow-3.26-3.11-2.190.62-16.15
Tangible Book Value Per Share0.250.320.411.160.07
Shareholders’ Equity Per Share0.250.320.411.160.07
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.00
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.43-0.43-0.50-0.36-0.35
Tax Burden1.001.001.001.001.00
Interest Burden1.001.001.000.710.96
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.910.890.921.350.86

Currency in USD